Abstract
The melanocortin receptors are a centrally and peripherally expressed family of Class A GPCRs with physiological roles, including pigmentation, steroidogenesis, energy homeostasis, and others yet to be fully characterized. There are five melanocortin receptor subtypes that, apart from the melanocortin-2 receptor (MC2R), are stimulated by a shared set of endogenous agonists. Until 2020, X-ray crystallographic and cryo-electron microscopic (cryo-EM) structures of these receptors were unavailable, and the investigation of their mechanisms of action and putative ligand-receptor interactions was driven by site-directed mutagenesis studies of the receptors and targeted structure-activity relationship (SAR) studies of the endogenous and derivative synthetic ligands. Synthetic derivatives of the endogenous agonist ligand α-MSH have evolved into a suite of powerful ligands such as NDP-MSH (melanotan I), melanotan II (MTII), and SHU9119. This suite of tool compounds now enables the study of the melanocortin receptors and serves as scaffolds for FDA-approved drugs, means of validating stably expressing melanocortin receptor cell lines, core ligands in assessing cryo-EM structures of active and inactive receptor complexes, and essential references for high-throughput discovery and mechanism of action studies. Herein, we review the history and significance of a finite set of these essential tool compounds and discuss how they are being utilized to further the field’s understanding of melanocortin receptor physiology and greater druggability.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2706-2724 |
| Number of pages | 19 |
| Journal | ACS Pharmacology and Translational Science |
| Volume | 7 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 13 2024 |
Bibliographical note
Publisher Copyright:© 2024 American Chemical Society.
Keywords
- AGRP
- NDP-MSH
- SHU9119
- afamelanotide
- bremelanotide
- setmelanotide
PubMed: MeSH publication types
- Journal Article